Cue Biopharma Leadership

Daniel 'Dan' Passeri is a Board Member at Cue Biopharma and is based in United States. He has worked as Chief Officer, Technology Management and Business Development at Jackson Laboratory/The; Senior VP:Corporate Dev at CURIS INC; and Vice Chairman at CURIS INC. Daniel works or has worked as New Company at Context Pharma. He attended University of London, The George Washington University School of Business between 1990 and 1994, and The George Washington University Law School between 1990 and 1994.

Anish Suri is a President/Chief Scientific Officer at Cue BioPharma Inc. He has worked as Asst Professor:Pathology & Immunology at WASHINGTON UNIVERSITY and Senior VP/Chief Scientific Officer at Cue BioPharma Inc. Anish studied at WASHINGTON UNIVERSITY.

Kenneth J. Pienta is a medical doctor and the Donald S. Coffey professor of urology and professor of oncology and pharmacology and molecular sciences at the Johns Hopkins University School of Medicine. He also serves as the director of research at the Brady Urological Institute.

Kerri-Ann Millar is a Chief Financial Officer at Cue Biopharma and is based in Lynnfield, Massachusetts. She has experience at Pricewaterhousecoopers LLP and has worked as Controller at Cue Biopharma; Audit Manager, Assistant Vice President at Brown Brothers Harriman; and VP:Finance at Cue Biopharma. Kerri-ann attended Boston University between 1988 and 1992.

Daniel 'Dan' Passeri is a Board Member at Cue Biopharma and is based in United States. He has worked as Chief Officer, Technology Management and Business Development at Jackson Laboratory/The; Senior VP:Corporate Dev at CURIS INC; and Vice Chairman at CURIS INC. Daniel works or has worked as New Company at Context Pharma. He attended University of London, The George Washington University School of Business between 1990 and 1994, and The George Washington University Law School between 1990 and 1994.

Kenneth J. Pienta is a medical doctor and the Donald S. Coffey professor of urology and professor of oncology and pharmacology and molecular sciences at the Johns Hopkins University School of Medicine. He also serves as the director of research at the Brady Urological Institute.